Case report: Mucosal leishmaniasis presenting with nasal septum perforation after almost thirty years
- ,
- Helena L. Frischtak,
- Jose Arenas,
- Andres G. Lescano
- ,
- Universidad Continental, Huancayo,
- University of Virginia School of Medicine,
- Hospital Guillermo Almenara Irigoyen,
- Universidad Peruana Cayetano Heredia
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 327-330 (4 pages)Journal (Volume, Issue Number)
American Journal of Tropical Medicine and Hygiene (Volume 99, Issue 2)Publication milestones
- Published - 2018
Publication status
ISSN
0002-9637Publication IDs
- Scopus: 85051076976
- PubMed: 29869609
Abstract
Mucosal leishmaniasis (ML) is associated with progressive tissue destruction and granuloma formation, often after a considerable period of latency from an initial cutaneous infection. We report a case of recurrent epistaxis of 3 years duration and nasopharyngeal obstruction in a woman with treated cutaneous leishmaniasis nearly 30 years before and with no further exposure to Leishmania. Computed tomography revealed nasal septal perforation and histopathology demonstrated chronic inflammation. Microscopy was negative for amastigotes, but molecular testing of nasal mucosa biopsy detected Leishmania (Viannia) braziliensis. The patient underwent 28 days of treatment with IV sodium stibogluconate and her symptoms improved significantly. Sixteen months after treatment, she continues to have episodic epistaxis and detectable parasite load in her nasal lesion. Although ML is known to take years to decades to develop, there are few reported cases in the literature of such a long latency period. This report highlights the importance of considering ML in the differential diagnosis of chronic epistaxis in countries where leishmaniasis is endemic or in immigrants from these countries, even when presentation occurs decades after leaving an endemic region.
Funding Details
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
